You'll see a new COX-2 inhibitor called Bextra (valdecoxib)

    You'll see a new COX-2 inhibitor called Bextra (valdecoxib).

It's being marketed by Pharmacia and Pfizer...the same companies that market Celebrex (celecoxib).

Bextra is approved for osteoarthritis, rheumatoid arthritis, and dysmenorrhea. It's NOT yet approved for acute pain.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote